<style face="normal" font="default" size="100%">The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Association between thyroid hormones and TRAIL.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">TRAIL modulates the immune system and protects against the development of diabetes.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">TRAIL as biomarker and potential therapeutic tool for cardiovascular diseases.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">TRAIL shows potential cardioprotective activity.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop.</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes.</style>